HUE029488T2 - Tiazolidindion vegyületek szintézise - Google Patents
Tiazolidindion vegyületek szintézise Download PDFInfo
- Publication number
- HUE029488T2 HUE029488T2 HUE11745671A HUE11745671A HUE029488T2 HU E029488 T2 HUE029488 T2 HU E029488T2 HU E11745671 A HUE11745671 A HU E11745671A HU E11745671 A HUE11745671 A HU E11745671A HU E029488 T2 HUE029488 T2 HU E029488T2
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- alkyl
- group
- aliphatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Claims (2)
1. S|äs 1;
R, es Es egpntaft liggöifcsÄ l&MögÉ*«% Ät> 8ffoä$» «IM«& #. :Ä*teppr&k; PæÂ:?g* Isseíöit. ahol m aitóí, »feil altéA vagy Ämiesoport »áoii m&bm 14- Mögéöst®ísmá sánbá&ímált; melynek sonie egv ;2A;:
kóptóu vsj^ÛM ïMp\M vegyilieïié siÄsfik, aboi R:5 iuè-ogêâtatom V*#'è#ÿ aÉ)ttesetb«â.;sA3l>sA3uÉli 14 g^oMbmôs sfkik:;Rp*i
2. As 1. igénypert sïoRoîî eljárás, melynek soráé továbbá egy 3A: képiéül: •vegytUetet egy 4A:
képiétfi vegyülöd rí&gáftoAntk; áltól X; kiléjtő csoport a 2A itoptslü ve^Uei elMIMiására. 3, Λ1 igénypont szerinti efárás, aksl a 4A keletű veuille? 4A1: képleté.
4: A 2. vagy 3. Igénypont sserinii eljárás, melynek során továbbá egy 5Â képiéin:
vegyöletoí, ahoi: Xí: klippé osöpofL 4A képklö; végvölettó ákklmok. 5. A 4, igénypont sárink eljárás, állói X; Itólogéiatö«* vagy tríMikmgwt. é. A 4, 'igáiypont sárink eljárás, melynek soráé tóvábfeé egy 6A képiéin:
vcgyóicíét almi X; kilépő csoport, 5A kèplelA vegyülsité alakituok, 7. A 6. igénypont sAtonri. eljárás, melynek során továbbá egy óA kóptoiú: vógyPietot Mogéttoeésad SA képleté \cgyületté.alakítunk. 8 Az l-7< igétApötti# bàrnîdyikc Mcnoti eljárás. akt H a## ssstben 1-3 ]»l^#8glïa»m8! sÄMftuÄt I -6 ÂMëi· alklicsopart Ψ A 24 .igénypertől: .Mmelvike sæ@âa£i eljárás, marnák során továbbá.«#1
képlett vspétetlsl 83B:
képlett vegyük* előállítására, és a 3B képletüvegyütei 3A képlett vegyületté redukáljuk. Hl Az t. igénypont szerinti eljárás. melynek során továbbá egy ?A:
képlett vegyitek! egy tA képlett yegpléöi ítaklttet. 11A 18. igátypoífó séertti eljárás, aM;« 7A képlett vegyfêim î^MôléMla^ÿdktkMiÂ' alakítjuk 2A képiétü vegyüleité 12. A 18. ágfeypost szerinti elárás^ nielynek söráe:toeáfebá:égy SA; képlet!! vegyöietet egy:
képiét!! vegyülettel reagáltatok* â TA képlet!! vegyükí előállítására, 13. A 12, igsayponi szerintii eljárás, áhöl a 8A képlet!! vegyuiet SAI; képlet«.
14. A 1,2. tgÉ!y:pö«í sxermö eljárás, .mélynek soráé un abba egy 4A: képletu vsgvüleiel egy
képlet!! vsgyülettel reagáltatok, a 8A képlet« vegyúlet előállítására. 15': Az b M. %áwpöMók bânmh·ikç szunuü eljárás, sfcöl Κ·* »Mil, etil, jMpi iztp'ogik butit vagy í'0tV"hiítil csoport, melyet mmdegyike adott esetbe» .1-3 Isalogémkommsl szubsztrtuáit 1b Λ ^ alábbiak.
ko?ûl választolt vegyidet, ahol R* htdrogénatöro vagy szebszüittálaila» 1.-6 szeusiomos alkilesoport.,.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37226910P | 2010-08-10 | 2010-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE029488T2 true HUE029488T2 (hu) | 2017-02-28 |
Family
ID=44504274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE11745671A HUE029488T2 (hu) | 2010-08-10 | 2011-08-09 | Tiazolidindion vegyületek szintézise |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8895748B2 (hu) |
| EP (1) | EP2603507B1 (hu) |
| JP (1) | JP5851506B2 (hu) |
| KR (1) | KR101857307B1 (hu) |
| CN (1) | CN103153991B (hu) |
| AU (1) | AU2011289627B2 (hu) |
| CA (1) | CA2807815C (hu) |
| ES (1) | ES2588769T3 (hu) |
| HU (1) | HUE029488T2 (hu) |
| MX (1) | MX342289B (hu) |
| NZ (1) | NZ606597A (hu) |
| PL (1) | PL2603507T3 (hu) |
| RU (1) | RU2594725C2 (hu) |
| WO (1) | WO2012021467A1 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ602883A (en) | 2010-04-19 | 2014-09-26 | Metabolic Solutions Dev Co Llc | Novel synthesis for thiazolidinedione compounds |
| CN103180304B (zh) * | 2010-08-10 | 2017-02-15 | 奥克泰塔治疗有限责任公司 | 噻唑烷二酮化合物的合成方法 |
| CN104496935A (zh) * | 2014-11-24 | 2015-04-08 | 苏州乔纳森新材料科技有限公司 | 一种胰岛素增敏剂中间体的合成方法 |
| CN109219594B (zh) | 2016-03-31 | 2022-10-11 | 英克特诺治疗公司 | 吲哚啉类似物及其用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| SU1766260A3 (ru) * | 1989-11-04 | 1992-09-30 | Пфайзер Инк (Фирма) | Способ получени производных тиазолидиндиона-2,4 или их фармацевтически приемлемых солей с щелочными металлами |
| US5143930A (en) | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| DE69231886T2 (de) * | 1991-04-11 | 2002-03-28 | Upjohn Co | Thiazolidindionderivate, herstellung und anwendung |
| SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | Astra Ab | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| AP869A (en) | 1998-01-05 | 2000-09-04 | Pfizer | 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents. |
| US7407978B2 (en) | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| JP2004514703A (ja) | 2000-12-01 | 2004-05-20 | ノバルティス アクチエンゲゼルシャフト | 有機化合物の組合せ剤 |
| WO2003029251A1 (en) | 2001-09-28 | 2003-04-10 | Biocon Limited | Novel process for the synthesis of thiazolidinedione derivatives |
| FR2861069B1 (fr) * | 2003-10-17 | 2005-12-09 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| NZ571871A (en) * | 2006-03-16 | 2011-07-29 | Metabolic Solutions Dev Co | Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease |
| US8435983B2 (en) | 2007-03-23 | 2013-05-07 | The University Of Toledo | Conformationally restrained epothilone analogues as anti-leukemic agents |
| WO2009038681A1 (en) * | 2007-09-14 | 2009-03-26 | Metabolic Solutions Development Company | Thiazolidinedione analogues for the treatment of hypertension |
| WO2009148195A1 (en) | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same |
| NZ602883A (en) | 2010-04-19 | 2014-09-26 | Metabolic Solutions Dev Co Llc | Novel synthesis for thiazolidinedione compounds |
| RU2012148909A (ru) | 2010-04-19 | 2014-05-27 | МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи | Новый синтез соединений тиазолидиндиона |
| CN103180304B (zh) | 2010-08-10 | 2017-02-15 | 奥克泰塔治疗有限责任公司 | 噻唑烷二酮化合物的合成方法 |
-
2011
- 2011-08-09 CA CA2807815A patent/CA2807815C/en active Active
- 2011-08-09 ES ES11745671.5T patent/ES2588769T3/es active Active
- 2011-08-09 US US13/813,462 patent/US8895748B2/en active Active
- 2011-08-09 CN CN201180048953.XA patent/CN103153991B/zh active Active
- 2011-08-09 AU AU2011289627A patent/AU2011289627B2/en not_active Ceased
- 2011-08-09 NZ NZ606597A patent/NZ606597A/en not_active IP Right Cessation
- 2011-08-09 EP EP11745671.5A patent/EP2603507B1/en active Active
- 2011-08-09 PL PL11745671.5T patent/PL2603507T3/pl unknown
- 2011-08-09 WO PCT/US2011/046992 patent/WO2012021467A1/en active Application Filing
- 2011-08-09 HU HUE11745671A patent/HUE029488T2/hu unknown
- 2011-08-09 JP JP2013524155A patent/JP5851506B2/ja not_active Expired - Fee Related
- 2011-08-09 RU RU2013110311/04A patent/RU2594725C2/ru active
- 2011-08-09 KR KR1020137006014A patent/KR101857307B1/ko active IP Right Grant
- 2011-08-09 MX MX2013001475A patent/MX342289B/es active IP Right Grant
-
2014
- 2014-09-05 US US14/478,184 patent/US8946435B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013001475A (es) | 2013-04-29 |
| MX342289B (es) | 2016-09-23 |
| AU2011289627A1 (en) | 2013-02-21 |
| US8946435B2 (en) | 2015-02-03 |
| EP2603507B1 (en) | 2016-06-29 |
| CN103153991A (zh) | 2013-06-12 |
| NZ606597A (en) | 2014-12-24 |
| ES2588769T3 (es) | 2016-11-04 |
| US8895748B2 (en) | 2014-11-25 |
| CA2807815A1 (en) | 2012-02-16 |
| CA2807815C (en) | 2018-10-02 |
| AU2011289627B2 (en) | 2015-01-15 |
| PL2603507T3 (pl) | 2016-12-30 |
| RU2013110311A (ru) | 2014-09-20 |
| RU2594725C2 (ru) | 2016-08-20 |
| US20130211092A1 (en) | 2013-08-15 |
| US20140378687A1 (en) | 2014-12-25 |
| CN103153991B (zh) | 2016-06-29 |
| WO2012021467A1 (en) | 2012-02-16 |
| JP5851506B2 (ja) | 2016-02-03 |
| JP2013535503A (ja) | 2013-09-12 |
| KR101857307B1 (ko) | 2018-05-11 |
| KR20130097750A (ko) | 2013-09-03 |
| EP2603507A1 (en) | 2013-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2513070T3 (en) | PPAR-sparing thiazolidinedione salts for the treatment of metabolic disorders | |
| WO2011133441A2 (en) | Novel synthesis for thiazolidinedione compounds | |
| WO2010105048A1 (en) | Thiazolidinedione analogues | |
| CA2796437C (en) | Novel synthesis for thiazolidinedione compounds | |
| US8946435B2 (en) | Synthesis for thiazolidinedione compounds | |
| EP2603498B1 (en) | Novel synthesis for thiazolidinedione compounds | |
| AU2013200104B2 (en) | Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease |